Monte Rosa Therapeutics News

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hughes Eric A

Dec 13 22:06

Monte Rosa Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hughes Eric A

Dec 13 22:01

Monte Rosa Therapeutics | 8-K: Current report

Dec 13 20:06

Monte Rosa Therapeutics | 8-K: Current report

Dec 5 20:04

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.8%)

Nov 15 02:40

Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(8.312%),Abigail P. Johnson(8.312%)

Nov 12 23:38

Monte Rosa Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 20:13

Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 7 20:08

Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.

Oct 31 05:13

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.

Oct 31 04:38

Monte Rosa Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 29 04:09

Monte Rosa Therapeutics | 8-K: Current report

Oct 28 19:03

Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(8.3%),Versant Ventures VI GP, L.P.(8.3%), etc.

Sep 25 05:02

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.

Sep 25 04:42

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.

Sep 14 06:46

Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Janku Filip

Sep 14 04:32

Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ali Behbahani(12.7%),New Enterprise Associates 17, L.P.(12.5%), etc.

Aug 13 07:51

Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(11.1%),Versant Ventures VI GP, L.P.(11.1%), etc.

Aug 13 05:11

Monte Rosa Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 19:09

Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8 19:04